Stay updated on Subcutaneous Durvalumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The Record History page lists a new Revision: v3.6.6, replacing v3.6.5, indicating a software/UI update to the history display.
    Difference
    0.1%
    Check dated 2026-08-29T20:58:14.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry labeled v3.6.5, and the previous v3.6.4 entry has been removed from the list.
    Difference
    0.1%
    Check dated 2026-08-08T16:12:56.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A new Revision: v3.6.4 entry was added to the record history, replacing the previous v3.6.3, signaling a small site update.
    Difference
    0.1%
    Check dated 2026-07-25T08:27:27.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The record history adds a new revision entry (v3.6.3) and removes the previous revision (v3.6.2), indicating a metadata/version update to the page.
    Difference
    0.1%
    Check dated 2026-07-03T20:25:53.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Updated the page's revision tag from v3.6.0 to v3.6.2. This reflects a newer build of the site interface rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-06-27T00:16:42.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page now indicates that enrollment has ceased for this study. It also adds a new revision tag 'Revision: v3.6.0' and removes the previous 'Revision: v3.5.5'.
    Difference
    0.5%
    Check dated 2026-06-12T23:44:30.000Z thumbnail image

Stay in the know with updates to Subcutaneous Durvalumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Subcutaneous Durvalumab in Lung Cancer Clinical Trial page.